about
Thermosensitive and mucoadhesive sol-gel composites of paclitaxel/dimethyl-β-cyclodextrin for buccal deliverySimultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography.Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery.Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.Development of docetaxel nanocrystals surface modified with transferrin for tumor targetingThe spermatogenic effect of yacon extract and its constituents and their inhibition effect of testosterone metabolism.Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.Effects of paclitaxel nanocrystals surface charge on cell internalization.Use of acidifier and solubilizer in tadalafil solid dispersion to enhance the in vitro dissolution and oral bioavailability in rats.Preparation and evaluation of solid lipid nanoparticles with JSH18 for skin-whitening efficacy.Melampolides from the leaves of Smallanthus sonchifolius and their inhibitory activity of lps-induced nitric oxide production.Folate-tethered emulsion for the target delivery of retinoids to cancer cells.Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes.Exploring the Preparation of Albendazole-Loaded Chitosan-Tripolyphosphate NanoparticlesAccelerated wound healing by smad3 antisense oligonucleotides-impregnated chitosan/alginate polyelectrolyte complex.7-O-methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro.A thermosensitive vaginal gel formulation with HPgammaCD for the pH-dependent release and solubilization of amphotericin B.Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release.The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration.Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.Determination of glimepiride in human plasma using semi-microbore high performance liquid chromatography with column-switching.Narrow-bore high performance liquid chromatographic method for the determination of cetirizine in human plasma using column switching.Pharmacokinetics of oral calcitriol in healthy human based on the analysis with an enzyme immunoassay.The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.Reparation of controlled release spheronized beads by simple extrusion and modified spheronization process.Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design.Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.Gold nanorod-photosensitizer conjugates with glutathione-sensitive linkages for synergistic cancer photodynamic/photothermal therapy.Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells.Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats.High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration.Preparation and characterization of mucoadhesive enteric-coating ginsenoside-loaded microparticles.Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.In vitro dissolution and in vivo bioequivalence evaluation of two brands of isosorbide 5-mononitrate sustained release tablets.Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate.
P50
Q28543507-7FC49766-9329-42D9-B79C-5783760F097CQ33207717-EDD271A5-204F-4719-B8B6-76C8BD8D9E65Q33676634-D949A673-6128-4337-99D4-4A15B82A77C8Q36010319-87FFDC62-6B85-4959-93A5-2CFCE696C62EQ36233487-F461E0A7-BE0C-4B80-95E1-56130B935857Q36235151-CEE79EA3-38A8-4935-A200-4975118B8F0FQ37145590-B28E147F-5315-461B-8366-09235AD8ED42Q38748290-78CDE07F-2712-468F-B195-D5C73B496081Q38752344-D4D73500-B49C-432C-A53C-DBB0007A9025Q38816099-BCFC9C7E-06E6-429F-9A2C-D2295A9BFD34Q39796119-03FC5230-133C-4DAE-AE48-390597539181Q40018234-937237CB-503E-47ED-955D-53842829D98EQ40064993-F96F2432-A454-44AA-A49E-D70140C05A8BQ40640916-F1280C7C-95DF-41C9-9E3D-4C74FF185B18Q42228549-9748C32F-B4BE-4FA2-84F3-C7D527D04FDBQ42807880-63D77ED5-EB08-4DFA-949C-6C8B2B1C1D72Q42820831-28B072EE-4EE6-4C89-9E63-3D93EBB34EB4Q42960326-86CBC3CA-08F5-4586-8E47-CDAA720E7A31Q43084494-FB2CFF35-668D-4266-A4E3-AC187CB71227Q43277736-425B293E-D3C9-4D89-9384-3507716339CFQ43298207-FBC77145-B931-4B9E-BB81-1EB12CB39505Q44869134-10FBD140-3A36-498D-BEE2-8121A42DD15DQ44992359-47D4B9FE-DDCE-438D-969A-66D48D09044BQ45052439-CF50E056-A254-4854-9EAE-AF41B94DF934Q45290727-B0499615-0304-4C18-90EC-13B8292D3E97Q46019223-86D3F3DE-2EFC-4025-91F4-49CF858D9C1AQ46559881-0D261867-1D05-4740-BD4D-0B6171960AA1Q46563083-71DC1804-73B6-4CEF-8F2D-A38257435498Q46604415-77CE9630-B5D4-469A-AA1B-B6688411A228Q46647331-E9D3CCE7-66A4-4298-8633-BFE07E331633Q46662356-2CC1547E-F733-40D6-AE7E-508ABD280649Q47210344-741ED7B5-FB85-45AB-B3E7-6A3185FC98BFQ47939197-E6883720-09FE-4356-9FCB-EF29DB984759Q48017917-76B9E514-921A-4885-AE82-C494BC49C157Q48260826-6CDACF51-B0E7-4601-8B63-14A975821863Q50471557-87EE6011-D18E-4DF5-896D-61E41A10AFCFQ50615200-BC0FFCE4-AD58-40E2-BFC6-682E07CDCE89Q51307024-EC46A36D-A8C6-4FA5-8D70-D2F3B8693685Q53126483-F000B843-6AA5-47DD-AAEA-E22C25A3B57FQ53129475-642E6D9C-517D-48FC-8A84-074A73F618B8
P50
description
researcher ORCID ID = 0000-0002-4081-213X
@en
wetenschapper
@nl
name
Jeong-Sook Park
@ast
Jeong-Sook Park
@en
Jeong-Sook Park
@es
Jeong-Sook Park
@nl
type
label
Jeong-Sook Park
@ast
Jeong-Sook Park
@en
Jeong-Sook Park
@es
Jeong-Sook Park
@nl
prefLabel
Jeong-Sook Park
@ast
Jeong-Sook Park
@en
Jeong-Sook Park
@es
Jeong-Sook Park
@nl
P106
P1153
9742975300
P31
P496
0000-0002-4081-213X